Lance Bass knows that fans want to know if N’Sync will be getting back together for a tour, but at the moment he’s got ...

Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in high-risk adults with type 2 diabetes.Approval of oral semaglutide ...

Authors say in those without diabetes, continuous glucose monitors are not a substitute for HbA1c. HealthDay News — Continuous glucose monitors (CGMs) do not accurately reflect blood sugar control in ...

Living with type 1 diabetes today is leaps and bounds easier than it was decades ago. Things are only getting better ...

The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes ...

A little more than a century ago a diagnosis of type 1 diabetes was a death sentence. Today, thanks to extraordinary ...

The US Food and Drug Administration (FDA) has approved Rybelsus (oral semaglutide) for reducing the risk of major adverse ...

Navigating life with diabetes is no small task. While millions of people across the globe living with diabetes enjoy full ...

When the body’s thirst control fails, water itself becomes the danger. Diabetes mellitus—commonly recognized as type 1 and ...